Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Nejad, E.B.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(10)
+
-
Availability
Open access
(7)
+
-
Metadata Only
(3)
+
-
Creation Date
2015
(2)
+
-
2020
(2)
+
-
Faculty
Faculty of Science
(1)
+
-
Leiden University Medical Center (LUMC)
(9)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(9)
+
-
Topic
immunotherapy
(4)
+
-
Cancer
(2)
+
-
active
(2)
+
-
tumor microenvironment
(2)
+
-
Author
Arens, R.
(10)
+
-
Nejad, E.B.
(10)
+
-
Burg, S.H. van der
(8)
+
-
Sluis, T.C. van der
(7)
+
-
Duikeren, S. van
(6)
+
-
Franken, K.L.M.C.
(4)
+
-
Melief, C.J.M.
(4)
+
-
Ossendorp, F.
(4)
+
-
Hall, T. van
(3)
+
-
Labrie, C.
(3)
+
-
Welters, M.J.P.
(3)
+
-
Abdelaal, T.
(2)
+
-
Beyrend, G.
(2)
+
-
Boon, L.
(2)
+
-
Cicin-Sain, L.
(2)
+
-
Elsas, M.J. van
(2)
+
-
Huppelschoten, S.
(2)
+
-
Jordanova, E.S.
(2)
+
-
Kleinovink, J.W.
(2)
+
-
Sloots, A.
(2)
+
-
Smit, V.T.H.B.M.
(2)
+
-
Water, B. van de
(2)
+
-
Show more
Language
en
(10)
+
-
Search results
(1 - 10 of 10)
show grid
show list
save search
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection
The importance of correctly timing cancer immunotherapy
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8(+) T Cells
Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death
Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death